Natalizumab: Immune Effects and Implications for Therapy
Ann Neurol 59:731-732, Hauser,S.L. &Weiner, H.L., 2006
CT and MR Imaging of Neuroaxonal Leukodystrophy Presenting as Early-Onset Frontal Dementia
AJNR 27:1037-1039, Mascalchi,M.,et al, 2006
Neuropathology of the Neuroradiologist: Rosenthal Fibers
AJNR 27:958-961, Wippold,F., II,et al, 2006
Diffusion MRI Abnormalities After Prolonged Febrile Seizures with Encephalopathy
Neurol 66:1304-1309, Takanashi,J.,et al, 2006
Past Adult Lead Exposure is Linked to Neurodegeneration Measured by Brain MRI
Neurol 66:1476-1484,1464, Stewart,W.F.,et al, 2006
Transmission of Lymphocytic Choriomeningitis Virus by Organ Transplantation
NEJM 354:2235-2249, Fischer,S.A.,et al, 2006
Multiple Sclerosis: The Role of MR Imaging
AJNR 27:1165-1176, Ge,Y., 2006
MR Imaging and Prognosis of Hypoxic-Ischemic Leukoencephalopathy
Neurocrit Care 4:119-126, Finelli,P. &DiMario,F.J. Jr., 2006
White Matter Alterations in Cerebral Amyloid Angiopathy Measured by Diffusion Tensor Imaging
Stroke 37:1759-1764, Salat,D.H., 2006
Progression of White Matter Lesions and Hemorrhages in Cerebral Amyloid Angiopathy
Neurol 67:83-87, Chen,Y.W.,et al, 2006
Significance of T2 Lesions in Multiple Sclerosis: A 13-Year Longitudinal Study
Ann Neurol 60:236-242, Rudick,R.A.,et al, 2006
Progressive Multifocal Leukoencephalopathy Revisited: Has the Disease Outgrown Its Name?
Ann Neurol 60:162-173, Koralnik,I.J., 2006
Characteristics and Antecedents of Progressive Multifocal Leukoencephalopathy in an Insured Population
Neurol 67:884-886, Eng,P.M.,et al, 2006
Neonatal MRI to Predict Neurodevelopmental Outcomes in Preterm Infants
NEJM 355:685-694,727, Woodward,L.J.,et al, 2006
Fragile X Premutation With Atypical Symptoms at Onset
Arch Neurol 63:1135-1138, Cellini,E.,et al, 2006
Seizures and Their Outcome in Progressive Multifocal Leukoencephalopathy
Neurol 66:262-264, Lima,M.A.,et al, 2006
Cerebral Microbleeds on MRI
Neurol 66:165-171, Koennecke,H.-C., 2006
Leukoencephalopathy, Cerebral Calcifications, and Cysts
AJNR 27:200-203, Sener,U.,et al, 2006
Prevalence of Fabry Disease in Patients with Cryptogenic Stroke: A Prospective Study
Lancet 366:1794-1796,1754, Rolfs,A.,et al, 2006
CT and MR Imaging Findings in Methanol Intoxication
AJNR 27:452-454, Blanco,M.,et al, 2006
Alexander Disease, Ventricular Garlands and Abnormalities of the Medulla and Spinal Cord
Neurol 66:494-498,468, van der Knaap,M.S.,et al, 2006
What Went Wrong in the Natalizumab Trials?
Lancet 367:706-709, Langer-Gould,A.&Steinman,L., 2006
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Evaluation of Patients Treated with Natalizumab for Progressive Multifocal Leukoencephalopathy
NEJM 354:924-933,965, Yousry,T.A.,et al, 2006
Gray and White Matter Brain Atrophy and Neuropsychological Impairment in Multiple Sclerosis
Neurol 66:685-692, Sanfilipo,M.P.,et al, 2006
Brain Abnormalities in Neuromyelitis Optica
Arch Neurol 63:390-396, Pittock,S.J.,et al, 2006
Combinations of the Presence or Absence of Cerebral Microbleeds and Advanced White Matter Hyperintensity as Predictors of Subsequent Stroke Types
AJNR 27:830-835, Naka,H.,et al, 2006
Pre- and Posttreatment MR Imaging Findings in Lead Encephalopathy
AJNR 27:902-903, Atre,A.L.,et al, 2006
Multiple Simultaneous Cerebral Infarctions in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
Cerebrovasc Dis 22:445-446, Gobron,C.,et al, 2006
Glycogen-Storage Disease Type II
eMedicine, May 2, Ibrahim,J. &McGovern,M., 2006
Dementia and White-Matter Demyelination in Young Patient With Neurosyphilis
Lancet:368:2258, Brinar,V.V. &Habek,M., 2006
Diffusion-Weighted Imaging and Proton MR Spectroscopy of White Matter Abnormalities in a Case of Phenylketonuria
Eur J Radiol Extra 54: 5-9, Teksam,M.,et al., 2005
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Diffusion-Weighted MR Imaging in Leukodystrophies
Eur Radiol 15:2284-2303, Patay,Z., 2005
Adrenoleukodystrophy
JAMA 294:3131-3134, Moser,H.W.,et al, 2005
Acute Encephalopathy Associated with Intravenous Immunoglobulin Therapy
AJNR 26:2311-2315, Wada,A.,et al, 2005
MR Imaging With Diffusion-Weighted Imaging in Acute and Chronic Wernicke Encephalopathy
AJNR 26:2306-2310, White,M.L.,et al, 2005
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005
Diffusion-Weighted MR Imaging of Early Methotrexate-Related Neurotoxicity in Children
AJNR 26:1686-1689, Fisher,M.J.,et al, 2005
Thiamine Deficiency in Infants: MR Findings in the Brain
AJNR 26:1668-1674, Kornreich,Ll,et al, 2005
Initial Diagnoses Given to Persons with the Fragile X Associated Tremor/Ataxia Syndrome (FXTAS)
Neurol 65:299-301, Hall,D.A.,et al, 2005
Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple Sclerosis
NEJM 353:369-374,414,432, Kleinschemidt-DeMasters,B.K. &Tyler,K.L., 2005
Progressive Multifocal Leukoencephalopathy After Natalizumab Therapy for Crohns Disease
NEJM 353:362-368, Van Assche,G.,et al, 2005
Progressive Multifocal Leukoencephalopathy in a Patient Treated with Natalizumab
NEJM 353:375-381, Langer-Gould,A.,et al, 2005
Neurologic Spectrum of Chronic Liver Failure and Basal Ganglia T1 Hyperintensity on Magnetic Resonance Imaging, Probably Manganese Neurotoxicity
Arch Neurol 62:1385-1390, Klos,K.J.,et al, 2005
In Utero Magnetic Resonance Imaging for Brain and Spinal Abnormalities in Fetuses
BMJ 331:562-565, Griffiths,P.D.,et al, 2005
Update on Primary Central Nervous System Lymphoma
Curr Opin Neurol 18:645-653, Plotkin,S.R., 2005
Sustained Recovery of Progressive Multifocal Leukoencephalopathy After Treatment with IL-2
Neurol 65:1510, Kunschner,L. &Scott,T.F., 2005
Central Nervous System Involvement in Hereditary Neuropathy With Liability to Pressure Palsies
Arch Neurol 62:1911-1914, Sanahuja,J.,et al, 2005
Capecitabine-Induced Multifocal Leukoencephalopathy: A Report of Five Cases
Neurol 65:1792-1794, Videnovic,A.,et al, 2005